Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy

Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy

Bibliographic Details
Main Authors:	Punzi, Henry, Shojaee, Ali, Maa, Jen-Fue
Format:	Online
Language:	English
Published:	SAGE Publications 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546644/

Similar Items

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
by: Punzi, Henry A
Published: (2011)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
by: Greathouse, Mark
Published: (2006)

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
by: Uddin, Ijlal, et al.
Published: (2010)

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
by: Sohn, Il Suk, et al.
Published: (2016)

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
by: Sohn, Il Suk, et al.
Published: (2015)

Olmesartan medoxomil: current status of its use in monotherapy
by: Brunner, Hans R
Published: (2006)

Central Composite Design for Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Tablets
by: Solanki, Trupti B., et al.
Published: (2014)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
by: Basile, Jan
Published: (2010)

Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis
by: Roth, Eli M, et al.
Published: (2013)

Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice
by: Bramlage, Peter, et al.
Published: (2014)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
by: Martinez-Martin, F J, et al.
Published: (2011)

Application of a Stability-Indicating HPTLC Method for Simultaneous Quantitative Determination of Olmesartan Medoxomil and Hydrochlorothiazide in Pharmaceutical Dosage Forms
by: Ilango, Kaliappan, et al.
Published: (2013)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
by: Tocci, Giuliano, et al.
Published: (2011)

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
by: Thakkar, Hetal Paresh, et al.
Published: (2011)

Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
by: Prajapati, Shailesh T., et al.
Published: (2013)

Small bowel enteropathy associated with olmesartan medoxomil treatment
by: Galanopoulos, Michail, et al.
Published: (2017)

Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique
by: Shah, SK, et al.
Published: (2012)

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis
by: Sievers, Philipp, et al.
Published: (2015)

Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension
by: Marques da Silva, Pedro, et al.
Published: (2015)

Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study
by: Hosoya, Tatsuo, et al.
Published: (2011)

Cost Minimization Analysis of Antihypertensive Therapy with Captopril-Hydrochlorothiazide and Amlodipine-Hydrochlorothiazide in One of Hospitals in Bandung
by: Andini Faramitha, et al.
Published: (2017-09-01)

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
by: Degli Esposti, Luca, et al.
Published: (2014)

Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age
by: Lewin, Andrew J., et al.
Published: (2013)

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual‐Combination Therapy
by: Rump, Lars C., et al.
Published: (2015)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
by: Mason, R Preston
Published: (2011)

Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil
by: Song, SaeHeum, et al.
Published: (2016)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
by: Niemeijer, Menco G., et al.
Published: (2009)

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
by: Stafylas, Panagiotis, et al.
Published: (2015)

Predictors of Participation in Mammography Screening among Non-Hispanic Black, Non-Hispanic White, and Hispanic Women
by: Melvin, Cathy L., et al.
Published: (2016)

Colorectal Cancer Test Use Among Hispanic and Non-Hispanic U.S. Populations
by: Pollack, Lori A, et al.
Published: (2006)

Attitudes of Hispanics and non‐Hispanics in the US: a comparative study of business ethics
by: Spero C., Peppas
Published: (2006)

Commentary – Comparing the Hispanic and Non‐Hispanic Markets: How Different Are They?
by: Michael, Minor
Published: (1992)

Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension
by: Weber, Michael A., et al.
Published: (2014)

Application of smart spectrophotometric methods and artificial neural network for the simultaneous quantitation of olmesartan medoxamil, amlodipine besylate and hydrochlorothiazide in their combined pharmaceutical dosage form
by: Darwish, Hany W
Published: (2013)

Simultaneous quantitative analysis of olmesartan, amlodipine and hydrochlorothiazide in their combined dosage form utilizing classical and alternating least squares based chemometric methods
by: Darwish Hany W., et al.
Published: (2016-03-01)

Environmental health and Hispanic children.
by: Metzger, R, et al.
Published: (1995)

Moyamoya in Hispanics: not Only in Japanese
by: Said, Sarmad, et al.
Published: (2014)

Web advertising and Hispanics
by: Pradeep, Korgaonkar, et al.
Published: (2001)

Hispanics and direct marketing advertising
by: Pradeep K., Korgaonkar, et al.
Published: (2000)

Contemporary Hispanic Quotations
Published: (2004)